Next-Generation Biotherapeutics Company Will Use Funds to Rapidly Advance Zybody Pipeline GAITHERSBURG, Md., Sept. 8 (HSMN NewsFeed) — Zyngenia, Inc., a privately held biotherapeutics company focused on next-generation antibody drug development, ann…
Biopharmaceuticals, Venture Capital
Zyngenia, Zybody

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Zyngenia, Inc. Raises $15 Million in Series A Extension Financing”
Leave a Comment